Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of duloxetine on Valsalva leak point pressure
2004-004160-67Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of duloxetine in stress urinary incontinence (SUI), sponsored by Eli Lilly and Company. Primary endpoint: Vesical Valsalva leak point pressure. Started Jul 2005; status: completed.
02
Drugs
duloxetine
03
Conditions
stress urinary incontinence (SUI)
Beyond the preview
Go deeper on 2004-004160-67.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004160-67.